Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Medchemcomm|July 16, 2019
Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potentialJake Smith, Heather Wescott, Julie Early, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Novel P4 truncated tripeptidyl alpha-ketoamides as HCV protease inhibitorsJason Lamar, Frantz Victor, Nancy Snyder, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitorsShu-Hui Chen, Jason Lamar, Frantz Victor, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitorsDavid X Sun, Lifei Liu, Beverly Heinz, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
P4 and P1' optimization of bicycloproline P2 bearing tetrapeptidyl alpha-ketoamides as HCV protease inhibitorsYvonne Yip, Frantz Victor, Jason Lamar, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitorsFrantz Victor, Jason Lamar, Nancy Snyder, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
P3 cap modified Phe*-Ala series BACE inhibitorsShu-Hui Chen, Jason Lamar, Deqi Guo, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SARJason Lamar, Jingdan Hu, Ana Belen Bueno, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2006
Design and synthesis of a novel class of dual PPARgamma/delta agonistsIsabel C Gonzalez, Jason Lamar, Fatima Iradier, et al.
Pageof 2